Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Low-Dose Versus High-Dose Alpha-Lipoic Acid in Acute Exacerbations of COPD
NCT07456176Phase 3Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Feb 2026
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alpha-lipoic acid in chronic obstructive pulmonary disease (COPD), sponsored by Ain Shams University. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
alpha-lipoic acid
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07456176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07456176.